IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars

Brands

Yourlist
Quizie
FaithTap
Blessed
All brands

Rosen Law Firm Warns Investors Ahead of DeadlinesBusiness — Aug 30, 2026Rosen Law Firm is alerting investors to potential eligibility for securities class actions across multiple companies, with lead plaintiff deadlines in late September to mid-October 2026 and the option to join without out-of-pocket costs. The notices emphasize contingency-fee arrangements and encourage timely action to pursue representation for Datavault AI, Cogent Communications, Rackspace Technology, UWM Holdings, and Pentair PLC investors.

Multiple Investor Class-Action Deadlines ApproachingBusiness — Aug 20, 2026Faruqi & Faruqi is warning investors about upcoming lead-plaintiff deadlines in securities class actions against Wise, Datavault AI, Wix, Blaize, and First Solar over alleged misstatements and overstated metrics. Deadlines range from September 22 to October 5, 2026, with actions already filed and potential recoveries for eligible investors.

J&J Wins FDA De Novo OTTAVA System — Jul 22, 2026Johnson & Johnson has received FDA De Novo clearance for its Ottava robotic surgical system, marking its entry into the U.S. market as a table-integrated, space-saving alternative aimed at general soft-tissue procedures. The company plans a selective U.S. rollout and ongoing global expansion, supported by an inguinal hernia trial and continued development of additional indications and regulatory approvals amid competition from Intuitive Surgical's established da Vinci platform.